Market News
Latest news from Stock markets.
EVTL Investors Have Opportunity to Join Vertical Aerospace Ltd. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $EVTL--EVTL Investors Have Opportunity to Join Vertical Aerospace Ltd. Fraud Investigation with the Schall Law Firm.
...keep reeding on businesswire.com
RR FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Richtech Robotics Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 3 Deadline in Securities Class Action Commenced by the Firm - RR
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Richtech Robotics Inc. (NASDAQ: RR) between January 27, 2026 and 12:00 PM ET on January 29, 2026, both dates inclusive (the "Class Period"), of the important April 3, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Richtech securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
ROSEN, A LONGSTANDING LAW FIRM, Encourages Hercules Capital, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HTGC
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Hercules Capital, Inc. (NYSE: HTGC) between May 1, 2025 and February 27, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.
...keep reeding on newsfilecorp.com
LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit First Filed by the Firm
NEW YORK, March 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lufax Holding Ltd (NYSE: LU) between April 7, 2023 and January 26, 2025, both dates inclusive (the "Class Period"), of the important May 20, 2026 in the securities class action first filed by the Firm. So What: If you purchased Lufax securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
HUBG Investor News: If You Have Suffered Losses in Hub Group, Inc. (NASDAQ: HUBG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Hub Group, Inc. (NASDAQ: HUBG) resulting from allegations that Hub Group may have issued materially misleading business information to the investing public.
...keep reeding on globenewswire.com
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of DNOW Inc. (NYSE: DNOW) resulting from allegations that DNOW Inc. may have issued materially misleading business information to the investing public.
...keep reeding on globenewswire.com
PLUG DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Plug Power Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 3 Deadline in Securities Class Action - PLUG
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Plug Power Inc. (NASDAQ: PLUG) between January 17, 2025 and November 13, 2025, inclusive (the "Class Period"), of the important April 3, 2026 lead plaintiff deadline. SO WHAT: If you purchased Plug Power securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
ROSEN, A LEADING LAW FIRM, Encourages ODDITY Tech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ODD
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of ODDITY Tech Ltd. (NASDAQ: ODD) between February 26, 2025 and February 24, 2026, inclusive (the "Class Period").
...keep reeding on newsfilecorp.com
VCIT vs. IGIB: Which Corporate Bond ETF Is Safer?
VCIT and IGIB offer a nearly identical cost and yield. Both ETFs posted the same 1-year total return and experienced similar drawdowns over the past five years.
...keep reeding on fool.com
FBRT Investors Have Opportunity to Lead Franklin BSP Realty Trust, Inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm
NEW YORK, March 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Franklin BSP Realty Trust, Inc. (NYSE: FBRT) between November 5, 2024 and February 11, 2026, both dates inclusive (the "Class Period"), of the important April 27, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased Franklin BSP Realty securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
SAN Investors Have Opportunity to Join Banco Santander, S.A. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $SAN--SAN Investors Have Opportunity to Join Banco Santander, S.A. Fraud Investigation with the Schall Law Firm.
...keep reeding on businesswire.com
Could Investing $10,000 in NOBL Make You a Millionaire?
The ProShares S&P 500 Dividend Aristocrats ETF has delivered average annual returns of 11% for the past 12 years. The fund holds only 69 stocks and is heavy on consumer staples, industrials, and financials.
...keep reeding on fool.com
BW Investors Have Opportunity to Join Babcock & Wilcox Enterprises, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $BW--BW Investors Have Opportunity to Join Babcock & Wilcox Enterprises, Inc. Fraud Investigation with the Schall Law Firm.
...keep reeding on businesswire.com
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit of Earlier Initiation of Repatha in High-Risk Patients, with Median 44 mg/dL LDL-C Achieved THOUSAND OAKS, Calif., March 28, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that Repatha® (evolocumab), when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering treatments, reduced the risk of first major adverse cardiovascular (CV) events (MACE) in high-risk primary prevention patients without known significant atherosclerosis (buildup of plaque in the arteries) and with diabetes.
...keep reeding on prnewswire.com
Greenland Energy (GLND) CEO: "Look Beyond the Strait of Hormuz" for Crude Oil
Robert Price, CEO of Greenland Energy (GLND), joins Trading 360 after the company began public trading this week. He says the U.S. and European allies need to "look beyond the Strait of Hormuz" for crude oil as his company begins to drill oil wells in Greenland.
...keep reeding on youtube.com
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead
The bulk of coverage towards the top gaining stock sectors over the past year has focused understandably on technology, which has made huge strides, with semiconductors exceeding +60%.
...keep reeding on 247wallst.com
YRD Investors Have Opportunity to Join Yiren Digital Ltd. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $YRD--YRD Investors Have Opportunity to Join Yiren Digital Ltd. Fraud Investigation with the Schall Law Firm.
...keep reeding on businesswire.com
ALIT Investors Have Opportunity to Lead Alight, Inc. Securities Fraud Lawsuit
NEW YORK, March 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alight, Inc. (NYSE: ALIT) between November 12, 2024 and February 18, 2026, both dates inclusive (the "Class Period"), of the important May 15, 2026 lead plaintiff deadline. So what: If you purchased Alight common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $PODD--PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm.
...keep reeding on businesswire.com
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Kyndryl Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - KD
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Kyndryl Holdings, Inc. (NYSE: KD) between August 7, 2024 and February 9, 2026, both dates inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kyndryl securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
INVESTOR ALERT: Trip.com Group Limited (TCOM) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
SAN DIEGO, March 28, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Trip.com Group Limited (NASDAQ: TCOM) publicly traded securities between April 30, 2024 and January 13, 2026, inclusive (the "Class Period"), have until Saturday, May 11, 2026 to seek appointment as lead plaintiff of the Trip.com class action lawsuit. Captioned De Wilde v.
...keep reeding on prnewswire.com
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz monotherapy in TOGETHER-PsA study Late-breaking results also published in Arthritis & Rheumatology INDIANAPOLIS, March 28, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from the TOGETHER-PsA open-label Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) compared to Taltz alone in adults with active psoriatic arthritis (PsA) and obesity or overweight with at least one additional weight-related comorbid condition. These results were presented in a late-breaking presentation at the 2026 American Academy of Dermatology (AAD) Annual Meeting and simultaneously published in Arthritis & Rheumatology.
...keep reeding on prnewswire.com
Incyte's skin disease drug shows long-term symptom relief in late-stage trials
Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in two late-stage trials.
...keep reeding on reuters.com
PRTH Investors Have the Opportunity to Join Investigation of Priority Technology Holdings, Inc. with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $PRTH--PRTH Investors Have the Opportunity to Join Investigation of Priority Technology Holdings, Inc. with the Schall Law Firm.
...keep reeding on businesswire.com
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
CAMBRIDGE, Mass., March 28, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced positive results from the Phase 2 part of the AMETHYST Phase 2/3 study (Part A) of litifilimab in people living with cutaneous lupus erythematosus (CLE). Litifilimab is the first humanized IgG1 monoclonal antibody (mAb) targeting blood dendritic cell antigen 2 (BDCA2), which has the potential to become the first innovative therapy approved for CLE in 70 years. Part A of AMETHYST evaluated the efficacy and safety of litifilimab through week 24, with reductions in skin disease activity reported across several measures. Results are consistent with the earlier positive Phase 2 LILAC study reported in The New England Journal of Medicine . Phase 2 results from LILAC and AMETHYST supported litifilimab's recently granted U.S. Food and Drug Administration (FDA) Breakthrough Therapy Designation. Results are being presented today at the American Academy of Dermatology (AAD) Annual Meeting.
...keep reeding on globenewswire.com
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
DURHAM, N.C., March 28, 2026 (GLOBE NEWSWIRE) -- Priovant Therapeutics, a clinical-stage biotechnology company focused on developing targeted therapeutics in autoimmune disease, announced today the publication of results from the Phase 3 VALOR trial evaluating brepocitinib in adults with dermatomyositis (DM) in the New England Journal of Medicine (NEJM).
...keep reeding on globenewswire.com
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
ZUG, Switzerland, March 28, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (MoonLake or the Company), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announces long-term Week 40 results of the Phase 3 VELA-1 and VELA-2 clinical trials of its registrational global program in patients with moderate-to-severe HS and confirms the presentation of the data at the 2026 American Academy of Dermatology (AAD) Annual Meeting later today.
...keep reeding on globenewswire.com
Takeda's Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda's Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care.
...keep reeding on businesswire.com
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #AAD2026--Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting.
...keep reeding on businesswire.com
Boston Beer vs Molson Coors: One Bets on Innovation, the Other Is Just Surviving
Boston Beer (NYSE: SAM) or Molson Coors Brewing (NYSE: TAP)—which one belongs in a retirement portfolio right now?
...keep reeding on 247wallst.com
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today presented late-breaking data from its MOMENTUM trial examining the prevalence of endogenous hypercortisolism in patients with resistant hypertension at the 2026 American College of Cardiology.
...keep reeding on businesswire.com
Investors Are Completely Wrong About Nvidia Stock
In this video, I will talk about Nvidia (NVDA 2.13%), the recent GTC news, and explain why the market is wrong. Watch the short video to learn more, consider subscribing, and click the special offer link below.
...keep reeding on fool.com
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lufax Holding Ltd Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - LU
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lufax Holding Ltd (NYSE: LU) between April 7, 2023 and January 26, 2025, both dates inclusive (the "Class Period"), of the important May 20, 2026 in the securities class action first filed by the Firm. SO WHAT: If you purchased Lufax securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and March 24, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
...keep reeding on newsfilecorp.com
A Fake headline Just Added and Erased $1.7 Trillion From the Stock Market
In this video, we look at where stocks go from here after four straight weeks of losses and whether this sell-off is a buying opportunity or the start of something worse. Watch the short video to learn more, consider subscribing, and click the special offer link below.
...keep reeding on fool.com
Here's What Investors Need to Know About AST SpaceMobile Stock's Recent Pullback
AST SpaceMobile aims to provide direct-to-device cellular service from its satellites. The company's shares are up more than 196% over the past year, but down sharply from their 52-week high.
...keep reeding on fool.com
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Lakeland Industries, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - LAKE
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lakeland Industries, Inc. (NASDAQ: LAKE) between December 1, 2023 and December 9, 2025, inclusive (the "Class Period"), of the important April 24, 2026 lead plaintiff deadline. SO WHAT: If you purchased Lakeland securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
SMR Investors Have Opportunity to Lead NuScale Power Corporation Securities Fraud Lawsuit
NEW YORK, March 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of NuScale Power Corporation (NYSE: SMR) between May 13, 2025 and November 6, 2025, inclusive (the "Class Period"), of the important April 20, 2026 lead plaintiff deadline. So what: If you purchased NuScale Class A common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nektar Therapeutics (NASDAQ: NKTR) between February 26, 2025 and December 15, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Nektar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
CRMT Investor News: If You Have Suffered Losses in America's Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America's Car-Mart, Inc. (NASDAQ: CRMT) resulting from allegations that America's Car-Mart may have issued materially misleading business information to the investing public.
...keep reeding on globenewswire.com
Here's ARK Innovation ETF's Vision for the Future. Do You Agree With It?
ARK Innovation ETF is an actively managed fund that invests in companies pursuing disruptive innovation. Such stocks have been highly volatile.
...keep reeding on fool.com
/C O R R E C T I O N -- Nestlé/
In the news release, Thieves Make a Break For It as 12 Tonnes of KITKAT Go Missing, issued 27-Mar-2026 by Nestlé over PR Newswire, we are advised by the
...keep reeding on prnewswire.com
The AI Honeymoon Is Over: Why $MSFT Is Tanking And What It Means For Your Portfolio
Microsoft stock has fallen 36% from its October 2025 all-time high. And 2026's first quarter could be the worst since the 2008 fourth quarter at the height of tie financial crisis, when the software giant's shares fell 27%, according to Bloomberg.
...keep reeding on forbes.com
Dual Imaging Identifies Cause of Heart Attack in Patients Without Blocked Arteries
/PRNewswire/ -- When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it could be a heart attack. She was 36, a
...keep reeding on prnewswire.com
An Alphatec VP Sold Company Shares Worth $1.4 Million. Should Investors Avoid the Stock?
Craig Hunsaker sold 116,367 shares across two open-market transactions on March 6 and March 9, 2026, for a total of ~$1.44 million at a weighted average price of $12.38 per share. This activity represented 6.32% of Hunsaker's direct holdings prior to the transaction, reducing direct ownership from approximately 1.84 million to 1.73 million shares.
...keep reeding on fool.com
Brazil Plant-Based Dairy Market to Reach USD 215 Million by 2032 Amid Rising Demand for Dairy Alternatives and Expanding Retail Presence| Vyansa Intelligence
/PRNewswire/ -- According to the in-depth study published by Vyansa Intelligence, the Brazil Plant-Based Dairy Market is projected to grow at a CAGR of around
...keep reeding on prnewswire.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nektar Therapeutics (NASDAQ: NKTR) between February 26, 2025 and December 15, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2026 lead plaintiff deadline.
...keep reeding on globenewswire.com
ROSEN, A LEADING LAW FIRM, Encourages Driven Brands Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DRVN
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Driven Brands Holdings Inc. (NASDAQ: DRVN) between May 9, 2023 and February 24, 2026, both dates inclusive (the "Class Period"), of the important May 8, 2026 lead plaintiff deadline. SO WHAT: If you purchased Driven Brands common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
RoboSense Crosses Into Profitability As Robotics Demand Powers Record Growth
RoboSense Technology Co., Ltd. has reported a quarterly net profit for the first time, pointing to a turning point as its robotics-focused LiDAR shipments surged.
...keep reeding on feeds.benzinga.com
ROSEN, A LONGSTANDING LAW FIRM, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. (NYSE: PFSI) resulting from allegations that PennyMac may have issued materially misleading business information to the investing public. SO WHAT: If you purchased PennyMac securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
MercadoLibre Stock Is on Sale. Here's What $5,000 Invested Today Could Do for Your Portfolio.
Investors are worried about new competition facing MercadoLibre. Margins are falling as it invests in the business.
...keep reeding on fool.com